Physician profile

Thomas J Dimino

Obstetrics & Gynecology · Miami, FL

NPI 1750311262

$1,198.75

in general payments reported to CMS, 2019-2025

17 companies · none reported in 2025

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $383.50 2019-2022
Allergan, INC. $130.19 2019
Hologic Sales and Service, LLC $99.06 2019-2022
Daiichi Sankyo INC. $98.60 2019-2022
Avion Pharmaceuticals $89.62 2020-2021
Mayne Pharma Commercial LLC $72.22 2022
Roche Diagnostics Corporation $64.01 2019-2021
Therapeuticsmd, INC. $50.32 2019-2020
Myovant Sciences INC. $38.91 2022
Bayer Healthcare Pharmaceuticals INC. $35.15 2019-2021
Radius Health, INC. $34.64 2019
Duchesnay USA Incorporated $26.68 2019
Agile Therapeutics, INC. $18.22 2021
Mylan Pharmaceuticals INC. $16.40 2019
Sage Therapeutics, LLC $15.43 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Lupin INC. $14.64 2019
Organon LLC $11.16 2022

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas J Dimino

$1,198.75

in general payments reported 2019-2025

Years
2019-2022
Top company
Abbvie INC.

https://glasscript.com/doctor/306503/thomas-j-dimino

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.